Saba Capital Management, L.P.'s Form 4 filing
abrdn Life Sciences Investors (HQL) · filed Sep 23, 2025
- Accession no.
- 0001510281-25-000498
- Filed
- Sep 23, 2025
- Trade date
- Sep 19-22, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $687.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Saba Capital Management, L.P.CIK 0001510281 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2025 | Common Stock | SSaleDisposed | −6,989 | $14.10 | −$98,544.9 | 2,879,256 | Indirect | |
| Sep 22, 2025 | Common Stock | SSaleDisposed | −41,623 | $14.14 | −$588,549.22 | 2,837,633 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.